IRIS UniCatt

Refolo, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.095
EU - Europa 11.708
AS - Asia 6.248
SA - Sud America 1.571
Continente sconosciuto - Info sul continente non disponibili 440
AF - Africa 205
OC - Oceania 63
Totale 33.330
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.528
IT - Italia 5.623
SG - Singapore 2.690
CN - Cina 1.597
DE - Germania 1.488
BR - Brasile 1.241
SE - Svezia 946
FR - Francia 867
VN - Vietnam 563
UA - Ucraina 522
GB - Regno Unito 455
IE - Irlanda 319
CA - Canada 285
NL - Olanda 242
ID - Indonesia 220
PL - Polonia 212
IN - India 189
RU - Federazione Russa 179
FI - Finlandia 175
BD - Bangladesh 150
HK - Hong Kong 139
GR - Grecia 138
JP - Giappone 135
MX - Messico 107
AR - Argentina 105
ES - Italia 105
TR - Turchia 90
CH - Svizzera 72
BE - Belgio 61
RO - Romania 57
IQ - Iraq 56
KR - Corea 56
AU - Australia 55
EC - Ecuador 53
IR - Iran 47
CO - Colombia 44
SA - Arabia Saudita 41
PK - Pakistan 40
ZA - Sudafrica 40
AT - Austria 37
NO - Norvegia 37
PE - Perù 37
CL - Cile 34
CR - Costa Rica 34
VE - Venezuela 32
CZ - Repubblica Ceca 30
IL - Israele 29
JM - Giamaica 28
CI - Costa d'Avorio 25
PH - Filippine 24
GE - Georgia 23
MA - Marocco 23
DK - Danimarca 22
KE - Kenya 22
VA - Santa Sede (Città del Vaticano) 19
MY - Malesia 18
TT - Trinidad e Tobago 18
TN - Tunisia 17
TW - Taiwan 17
DZ - Algeria 16
PR - Porto Rico 16
UZ - Uzbekistan 16
AL - Albania 15
LT - Lituania 15
HN - Honduras 14
AE - Emirati Arabi Uniti 13
EG - Egitto 13
JO - Giordania 13
PA - Panama 12
EU - Europa 11
PY - Paraguay 11
TH - Thailandia 11
BB - Barbados 10
SC - Seychelles 10
CW - ???statistics.table.value.countryCode.CW??? 9
NG - Nigeria 9
PT - Portogallo 9
KZ - Kazakistan 8
NI - Nicaragua 8
NP - Nepal 8
NZ - Nuova Zelanda 8
SV - El Salvador 8
BG - Bulgaria 7
ET - Etiopia 7
GT - Guatemala 7
UY - Uruguay 7
AZ - Azerbaigian 6
BH - Bahrain 6
DO - Repubblica Dominicana 6
EE - Estonia 6
LV - Lettonia 6
BA - Bosnia-Erzegovina 5
BS - Bahamas 5
BZ - Belize 5
HR - Croazia 5
HU - Ungheria 5
KG - Kirghizistan 5
MD - Moldavia 5
MK - Macedonia 5
OM - Oman 5
Totale 32.824
Salva come PNG Salva come JPEG
Città #
Ashburn 2.391
Singapore 1.172
San Jose 875
Chandler 850
Rome 781
Milan 638
Jacksonville 380
Beijing 318
Dublin 300
San Mateo 208
Nanjing 196
Lauterbourg 191
Los Angeles 191
New York 187
Jakarta 185
Wilmington 184
Ho Chi Minh City 182
Houston 179
Ann Arbor 174
Cattolica 172
Redwood City 162
São Paulo 161
Woodbridge 156
Hanoi 147
Kraków 137
Council Bluffs 126
Dallas 122
Munich 121
Tokyo 117
Hefei 113
Hong Kong 113
Fairfield 112
Boston 109
Turin 104
Moscow 98
Dearborn 96
The Dalles 96
Marseille 91
Chicago 87
Seattle 87
Lawrence 86
Boardman 83
Frankfurt am Main 83
Santa Clara 82
Bologna 81
Naples 80
Atlanta 79
Buffalo 77
Nanchang 77
Palermo 69
Princeton 66
Redmond 65
Toronto 63
Brooklyn 54
Florence 54
London 51
Phoenix 51
Athens 49
Basingstoke 49
Cambridge 48
Denver 44
Paris 44
Philadelphia 44
Bremen 43
Tukwila 43
Helsinki 42
Nürnberg 42
Kunming 40
Rio de Janeiro 40
Seoul 39
Norwalk 38
Tianjin 38
Brussels 37
Amsterdam 36
Izmir 36
Orem 36
Shanghai 36
Catania 35
Guangzhou 35
Bari 33
Thessaloniki 33
North Bergen 32
Warsaw 32
Brescia 31
Mountain View 31
Shenyang 31
Zurich 31
San Diego 30
Brasília 29
Hangzhou 29
Lancaster 29
Las Vegas 29
Verona 29
Hebei 28
San José 28
Washington 28
Da Nang 27
Manchester 27
Quito 27
San Francisco 27
Totale 14.825
Salva come PNG Salva come JPEG
Nome #
Il personalismo ontologicamente fondato come approccio per le analisi etiche nei processi di HTA 2.178
Ethical, Legal, and Social Assessment of AI-Based Technologies for Prevention and Diagnosis of Rare Diseases in Health Technology Assessment Processes 973
Principio di socialità 848
Guidance on choosing qualitative evidence synthesis methods for use in health technology assessments of complex interventions 541
Editing genetico: nuova questione bioetica? 342
Antropologia medica 336
Giustizia intergenerazionale in sanità. Il caso della valutazione dei “farmaci insostenibili 335
HTA of alternative methods of pathogen inactivation of fresh frozen plasma 316
Le esperienze di analisi ELSI in processi di HTA dell’Istituto di Bioetica e Medical Humanities dell’Università Cattolica del Sacro Cuore di Roma: un aggiornamento 291
EUnetHTA Joint-Action 1. HTA Core Model Application for Diagnostic Technologies (1.1). Prognostic tests for breast cancer recurrence (uPA/PAI-1 [FEMTELLE], MammaPrint, Oncotype DX). Ethical analysis 281
The ethical assessment in HTA reports: the development and the evolution of the ethics consultation by Institute of Bioethics of the Università Cattolica del Sacro Cuore, Rome (Italy) 269
Full HTA di Emicizumab 267
Allogeneic versus Autologous: ethical issues in umbilical cord blood use 250
Gene editing: a new issue for bioethics? 247
The ethical relevance of explainibility for AI-solutions for early diagnosis of dementia 242
Introduction to Ethics in Health Technology Assessment. HTAi 2021 Annual Meeting 242
How could Ethical, Legal, Social & Organizational issues be further integrated in HTA processes? A proposal of “extended” ELSI logics: justifications and considerations moving from the debate and the experience. 240
The 13-valent pneumococcal conjugated vaccine introduction in subjects aged >50 years: the result of a Health Technology Assessment 235
The “triangular model” applied to drug eluting stents (DES) 232
The 13-valent pneumococcal conjugated vaccine introduction in subjects aged> 50 years: the result of a Health Technology Assessment 225
HEALTH TECHNOLOGY ASSESSMENT (HTA) E VALUTAZIONE ETICA 224
Un altro tipo di consulenza etica in ambito sanitario: l’analisi etica nei processi di Health Technology Assessment (HTA) 224
Allocare risorse nel settore di farmaci biologici: il caso di Etanercept per il trattamento dell’artrite reumatoide 223
Health Technology Assessment di ausili assorbenti per l’incontinenza urinaria 223
Lo sviluppo della consulenza etica nei processi di HTA: i dati preliminari dell'esperienza dell'Istituto di Bioetica dell'Università Cattolica del Sacro Cuore (Roma) 216
RAPID RELATIVE EFFECTIVENESS ASSESSMENT OF NEW PHARMACEUTICALS FOR THE TREATMENT OF CHRONIC HEPATITIS C.POTENTIAL ETHICAL, ORGANISATIONAL, SOCIAL, AND LEGAL ASPECTS 214
The retrieval and critical appraisal of literature on patient preferences for treatment outcomes 211
Informed consent in medically assisted procreation in Italy: medico-legal and ethical challenges shaping physician responsibility 210
Il ruolo dei Real World Data (RWD) nell’Health Technology Assessment (HTA). La lezione della filosofia della scienza e del Progetto VALIDATE 209
Clinical ethics consultation as “shared document”. Emerging ethical and medico-legal issues: Sacchini D., Corsano B., Refolo P., Minacori R., Spagnolo A.G.the experience of IBioMedH-UCSC CEC Service (2005-2016) 207
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use 206
Triage in emergenza pandemica: sui rischi di una carrellologia 205
Modelli etici in Bioetica 204
Health Technology Assessment di icodec per la gestione dei pazienti affetti da diabete in Italia 202
Analisi etica. Report HTA del vaccino quadrivalente ad alto dosaggio (QIV-HD) EFLUELDA® per la prevenzione dell’influenza stagionale e delle sue complicanze nella popolazione over 65 202
E-recruitment based clinical research: notes for Research Ethics Committees/Institutional Review Boards 193
Le valutazioni etiche e quelle di HTA confermano il profilo di efficacia e sicurezza delle nuove terapie 189
Aspetti sociali. Report HTA del vaccino quadrivalente ad alto dosaggio (QIV-HD) EFLUELDA® per la prevenzione dell’influenza stagionale e delle sue complicanze nella popolazione over 65 189
Le competenze essenziali per la consulenza etica in ambito sanitario 188
Exploring the ethical issues of digital therapeutics (DTx) 186
The ethical assessment of nanotechnologies within HTA processes 186
Introduction to Ethics in Health Technology Assessment 186
Prioritization of high-cost new drugs for HCV: making sustainability ethical 180
The New Italian Guidelines for Assisted Reproduction Technologies (ART): Ethical and Medico-Legal Issues 179
Le analisi etiche nei processi di HTA nell'esperienza dell'Istituto di Bioetica della Facoltà di Medicina e chirurgia “A. Gemelli” dell'Università Cattolica del Sacro Cuore di Roma 179
Responsibility: A “first person ethics” for vaccination 176
Aspetti legali. Report HTA del vaccino quadrivalente ad alto dosaggio (QIV-HD) EFLUELDA® per la prevenzione dell’influenza stagionale e delle sue complicanze nella popolazione over 65 173
Electronic Medical Diary (EMD): ethical analysis in a HTA process 172
Valutazione multidimensionale e multidisciplinare del servizio di consegna domiciliare dei presidi medici per stomia e incontinenza 172
Aspetti bioetici della gestione delle epatiti in Italia 171
Why is it difficult to integrate ethics in HTA?. The epistemological viewpoint 171
Ethical issues in the use of genetic predictions of aggressive behavior in the criminal justice system: a systematic review 170
Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system 170
THE ETHICAL DOMAIN IN HEALTH TECHNOLOGY ASSESSMENT (HTA): BASICS, APPROACHES AND ISSUES 170
Which kind of ethical issues in HTA processes? Results and considerations from the application of ethics expertise in HTA processes in Italy 169
Italian Palliative Care Services: The Role of Patients' and Professionals' Views in Health Technology Assessment Scope Development 169
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 166
The ethical assessment of nanotechnologies for HTA 166
The six-year experience of the Italian Master in “Clinical Bioethics Consultation” (2013-2018) 166
Ethical aspects of Fecal Microbiota Transplantation (FMT) 165
Ethics and economics: the case of prenatal technologies. HTA for evidence-based public health 163
HTA processes for nanotechnologies: the ethical domain. 162
Bioética clínica. Documento de Trento. La consulta ética en el ámbito sanitario en Italia 162
L’uso di Internet nei trial clinici 161
Integrated assessment of home based palliative care with and without reinforced caregiver support: ‘A demonstration of INTEGRATE-HTA methodological guidances’ – Executive Summary 159
Assessing social and economic impact of subcutaneous mAbs in oncology 159
Costs of new anti Hepatitis C regimens and access to care: the case for prioritization or universal cure 159
Digital Technology and Healthcare: The Role of Health Technology Assessment 159
Theories of technological development and HTA 158
Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors 158
Assessing social and Economic Impact of Subcutaneous Mabs in Oncology 158
Etica e HTA: sulle difficoltà epistemologiche della loro integrazione 157
Attitudes of physicians, nurses, and the general public toward End‑of‑Life (EoL) decisions in European countries: an umbrella review 157
Il dibattito etico-deontologico sul compenso economico per la donazione di sangue 156
Test genetici in oncologia e comunicazione intrafamiliare: autonomia vs responsabilità 156
Il processo di HTA e la valutazione delle nanotecnologie 155
Towards an integrated assessment of complex health interventions. Results of the European INTEGRATE-HTA project 153
Chapter 2. The fact/value dichotomy 153
Patient-reported outcomes (PROs): The significante of using humanistic measures in clinical trial and clinical practice. 152
Ética y colocación de los recursos en la salud 152
Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors 151
Sull'inizio e sulla fine. L'accoglienza della nascita e le decisioni di fine vita 149
Analisi degli aspetti etici legati all’introduzione di rucaparib (RUBRACA) nel Servizio Sanitario Nazionale 148
Which core competencies for ethical expertise in healthcare field? 148
EAPC2016: Abstracts 146
[Patient-reported outcomes (PRO): historical profile, definitions, classifications and problems] 145
Should Artificial Intelligence-Based Patient Preference Predictors Be Used for Incapacitated Patients? A Scoping Review of Reasons to Facilitate Medico-Legal Considerations 144
VALIDATE consensus statement: integrating empirical and ethical inquiry in health technology assessment 143
Ethics of digital therapeutics (DTx) 141
What Type of Person Should I Be? About the Appeal to Virtues in Public Health Interventions 141
Assessing innovative technologies for secondary prevention and diagnosis: the MELCAYA project 140
Research Ethics Committees and clinical research in Italy: where are we going? 140
The development of PubMed search strategies for patient preferences for treatment outcomes 139
Mobbing 138
Documento di Trento. La consulenza etica in ambito sanitario in Italia 137
Sustainability of national health services and justice: the case of new DAAs for HCV in Italy 137
Implementing carrier screening for cystic fibrosis outside the clinic: ethical analysis in the light of the personalist view 135
2008-18 HTA Experience Of The UCSC Inst. Of Bioethics And MH – Rome (IT) 135
Health Technology Assessment (HTA): ethical aspects 134
Sulla “doverosità morale” dell’uso di vaccini 134
Totale 22.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.459
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.744 0 0 0 0 217 143 155 296 124 134 334 341
2022/20233.509 415 361 270 440 256 427 242 311 371 101 202 113
2023/20242.640 191 453 87 265 141 250 164 238 89 177 198 387
2024/20254.105 172 199 325 233 330 171 210 214 521 361 741 628
2025/20269.364 1.352 360 565 847 1.288 424 1.330 475 529 699 1.241 254
2026/20274.277 369 994 773 1.950 191 0 0 0 0 0 0 0
Totale 33.330